ES2941463T3 - Composiciones para el tratamiento de la dermatitis atópica - Google Patents
Composiciones para el tratamiento de la dermatitis atópica Download PDFInfo
- Publication number
- ES2941463T3 ES2941463T3 ES17871044T ES17871044T ES2941463T3 ES 2941463 T3 ES2941463 T3 ES 2941463T3 ES 17871044 T ES17871044 T ES 17871044T ES 17871044 T ES17871044 T ES 17871044T ES 2941463 T3 ES2941463 T3 ES 2941463T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- compound
- alkyl
- composition
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/02—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains containing only carbon and hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/04—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
- C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/14—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/14—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms
- C07C403/16—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms not being part of —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/18—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662423783P | 2016-11-18 | 2016-11-18 | |
PCT/US2017/062121 WO2018094122A1 (fr) | 2016-11-18 | 2017-11-17 | Procédés et compositions pour le traitement de la dermatite atopique |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2941463T3 true ES2941463T3 (es) | 2023-05-23 |
Family
ID=62145760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES17871044T Active ES2941463T3 (es) | 2016-11-18 | 2017-11-17 | Composiciones para el tratamiento de la dermatitis atópica |
Country Status (13)
Country | Link |
---|---|
US (1) | US11364209B2 (fr) |
EP (1) | EP3541777B1 (fr) |
JP (2) | JP7104989B2 (fr) |
KR (1) | KR102433721B1 (fr) |
CN (1) | CN110088073B (fr) |
AU (1) | AU2017363153B2 (fr) |
CA (1) | CA3043036A1 (fr) |
DK (1) | DK3541777T3 (fr) |
ES (1) | ES2941463T3 (fr) |
PL (1) | PL3541777T3 (fr) |
TW (1) | TWI746701B (fr) |
WO (1) | WO2018094122A1 (fr) |
ZA (1) | ZA201903005B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102272914B1 (ko) * | 2019-10-17 | 2021-07-05 | 한국전력공사 | 지하전력구 비상탈출 안전유도 시스템 |
JP2023517118A (ja) * | 2020-03-13 | 2023-04-21 | メディヘルプライン カンパニー,リミテッド | Tlsp抑制および皮膚炎症性疾患の治療または改善のための龍眼肉含有混合生薬抽出物を含む局所用組成物およびその使用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4031893A (en) | 1976-05-14 | 1977-06-28 | Survival Technology, Inc. | Hypodermic injection device having means for varying the medicament capacity thereof |
WO1993019748A1 (fr) * | 1992-04-02 | 1993-10-14 | Smithkline Beecham Corporation | Composes utiles pour traiter des maladies inflammatoires et inhiber la production du facteur necrosant de tumeurs malignes |
JPH07258091A (ja) * | 1994-03-17 | 1995-10-09 | Kyowa Hakko Kogyo Co Ltd | アトピー性皮膚炎治療剤 |
JP2000086529A (ja) | 1998-09-10 | 2000-03-28 | Kao Corp | Il−4産生抑制剤 |
US20080234225A1 (en) * | 2004-03-15 | 2008-09-25 | John Lezdey | Method of treatment |
TWI394572B (zh) | 2007-06-12 | 2013-05-01 | Golden Biotechnology Corp | Application of Cynanchum aurantii Cyclohexenone Compounds in the Preparation of Drugs for the Treatment of Autoimmune Diseases |
TWI583376B (zh) * | 2013-03-20 | 2017-05-21 | Hui-Ling Zeng | Compounds isolated from Antelroxicus and their use |
US9249117B2 (en) * | 2014-05-20 | 2016-02-02 | Hui Ling Tseng | Use of compounds from Antrodia camphorata in manufacturing medicaments for treating kidney diseases |
WO2016011130A1 (fr) * | 2014-07-17 | 2016-01-21 | National Taiwan University | Compositions et procédés pour la préparation de composés 4-oxy-2-cyclohexénone et 6-oxy-2-cyclohexénone |
CN105732381B (zh) * | 2014-12-30 | 2021-07-20 | 合一生技股份有限公司 | 牛樟芝提取物及其制备方法和应用 |
-
2017
- 2017-11-17 JP JP2019523843A patent/JP7104989B2/ja active Active
- 2017-11-17 DK DK17871044.8T patent/DK3541777T3/da active
- 2017-11-17 EP EP17871044.8A patent/EP3541777B1/fr active Active
- 2017-11-17 AU AU2017363153A patent/AU2017363153B2/en active Active
- 2017-11-17 CA CA3043036A patent/CA3043036A1/fr active Pending
- 2017-11-17 US US16/349,155 patent/US11364209B2/en active Active
- 2017-11-17 CN CN201780069697.XA patent/CN110088073B/zh active Active
- 2017-11-17 PL PL17871044.8T patent/PL3541777T3/pl unknown
- 2017-11-17 WO PCT/US2017/062121 patent/WO2018094122A1/fr unknown
- 2017-11-17 KR KR1020197017178A patent/KR102433721B1/ko active IP Right Grant
- 2017-11-17 TW TW106139823A patent/TWI746701B/zh active
- 2017-11-17 ES ES17871044T patent/ES2941463T3/es active Active
-
2019
- 2019-05-14 ZA ZA2019/03005A patent/ZA201903005B/en unknown
-
2022
- 2022-05-10 JP JP2022077700A patent/JP2022116021A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2018094122A1 (fr) | 2018-05-24 |
US20190282515A1 (en) | 2019-09-19 |
EP3541777A4 (fr) | 2020-07-29 |
JP7104989B2 (ja) | 2022-07-22 |
KR102433721B1 (ko) | 2022-08-19 |
ZA201903005B (en) | 2020-01-29 |
CN110088073A (zh) | 2019-08-02 |
TW201825083A (zh) | 2018-07-16 |
JP2019535697A (ja) | 2019-12-12 |
EP3541777A1 (fr) | 2019-09-25 |
CN110088073B (zh) | 2023-01-10 |
AU2017363153B2 (en) | 2022-02-17 |
PL3541777T3 (pl) | 2023-09-25 |
JP2022116021A (ja) | 2022-08-09 |
US11364209B2 (en) | 2022-06-21 |
CA3043036A1 (fr) | 2018-05-24 |
TWI746701B (zh) | 2021-11-21 |
KR20190086506A (ko) | 2019-07-22 |
DK3541777T3 (da) | 2023-03-27 |
AU2017363153A1 (en) | 2019-05-23 |
EP3541777B1 (fr) | 2023-01-11 |
WO2018094122A8 (fr) | 2019-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6159084B2 (ja) | 酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物 | |
ES2788598T3 (es) | Métodos y composiciones para tratar enfermedades neurodegenerativas | |
JP6663052B2 (ja) | GPCR19作用剤を有効成分として含有するアレルギー性皮膚疾患の予防又は治療用の組成物{Composition for preventing or treating allergic dermatitis comprising GPCR19 agonist as an active ingredient} | |
US10406120B2 (en) | Methods and compositions for treating kidney disorders | |
JP2022116021A (ja) | アトピー性皮膚炎を処置するための方法および組成物 | |
US20130158113A1 (en) | Methods and compositions for treating brain cancer | |
ES2886345T3 (es) | Métodos y composiciones para el tratamiento de enfermedades vasculares arterioescleróticas | |
KR20240032428A (ko) | 무화과 추출물을 포함하는 건선의 예방 및 치료용 조성물 | |
BRPI0709477A2 (pt) | uso de um composto | |
KR20240008375A (ko) | 건선을 치료하기 위한 약제의 제조에서의 망고스틴 과일 껍질 추출물의 용도 | |
US20130203861A1 (en) | Methods and compositions for treating ovarian cancer | |
KR101708761B1 (ko) | 퓨린 유도체 또는 그의 염을 포함하는 아토피성 피부염의 예방 또는 치료용 조성물 | |
JPH06239757A (ja) | 抗アレルギー剤 | |
CN114539092B (zh) | 一种燕麦麸酚酰胺生物碱及其制备方法与在制备止痒产品中的应用 | |
CN111971037A (zh) | 用于治疗特应症或瘙痒症的包含n-乙酰基氨基酸或n-酰基氨基酸的组合物 | |
US20230190680A1 (en) | Methods and compositions for treating an rna virus induced disease | |
CN115192639B (zh) | 一种治疗湿疹的药物及其制备方法 | |
TW202337488A (zh) | 白及萃取物治療嗜中性白血球活化失調相關疾病的用途 | |
KR20130062246A (ko) | 피톤치드를 유효성분으로 포함하는 천식의 예방 또는 치료용 조성물 | |
KR20170050540A (ko) | 메트포민을 유효성분으로 포함하는 피부질환 예방 또는 치료용 약학적 조성물 | |
AU2012207083A1 (en) | Methods and compositions for treating kidney disorders |